Publication | Closed Access
2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial
10
Citations
23
References
2016
Year
DP001 safely and effectively suppressed iPTH in hemodialysis patients with SHPT that were previously managed with active vitamin D alone or with a calcimimetic (www.clinicaltrials.gov, NCT01922843).
| Year | Citations | |
|---|---|---|
Page 1
Page 1